On January 28, 2022, Vineet R. Jindal notified Reneo Pharmaceuticals, Inc. of his intention to resign from his position as the Company's Chief Financial Officer, effective as of March 31, 2022 (the Separation Date").
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.67 USD | -1.76% | +0.60% | +4.38% |
05-16 | Reneo Pharmaceuticals Insider Bought Shares Worth $639,578, According to a Recent SEC Filing | MT |
05-13 | Reneo Pharmaceuticals to Merge With OnKure in All-Stock Deal -- Reneo Shares Rise | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.38% | 55.81M | |
+51.85% | 57.87B | |
+41.76% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- RPHM Stock
- News Reneo Pharmaceuticals, Inc.
- Vineet R. Jindal to Resign as Reneo Pharmaceuticals, Inc.'s Chief Financial Officer, Effective March 31, 2022